EXAME Magazine publishes 100 Best Companies to Work For list
Zoetis Feature Stories
Up to 20 percent of food production animals are lost to disease annually with an associated cost of $120 billion from 1995 to 2008, according to the World Organisation for Animal Health (OIE). Preventing and controlling infectious diseases is important to protect animal and human health; to help assure a safe, sustainable supply of animal protein; and to safeguard the livelihoods of farmers.
Você S/A includes Zoetis in 150 Best Companies to Work For list
At Zoetis, we know the human-animal bond is powerful. We’ve supported studies to show the benefits of therapy dogs for oncology patients and raised awareness about the ways pets can make people healthier. Now our colleagues in Spain are building on this work by sponsoring therapy dogs for children with autism, to help them develop social skills for the future. Read on to learn more about how these dogs, with the help of Zoetis, are making a difference in children’s lives.
Attributing much of his success to a curiosity for learning through different experiences
Zoetis donates products and services to animals in the South Pacific
The A.L.P.H.A. initiative progresses with local partnerships, veterinary training, and responding to emerging disease
Roni Thebo, R&D Director, Named 2018 Working Mother of the Year
Learn about scientific insights into the biology of skin allergy conditions in dogs from Dr. Andrea Gonzales of Zoetis
Brazil’s leading business magazine, EXAME, recently released their annual 1000 Best and Biggest Companies list, which highlights the strongest performing companies in the country. Zoetis is featured for the fourth year running, with improved rankings from previous years. Zoetis is the only animal health company in the pharmaceutical segment of the list to rank among the top 15.
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.